Fosun Pharma Forms China JV with Canada’s Atrium Innovation

Fosun Pharma has formed a China distribution JV with Atrium Innovations, a dietary supplement company headquartered in Canada. Initially, the JV, which will be called Fosium Innovations, will import and sell Atrium’s Pure Encapsulations® line of supplements in China. Atrium paid $1 million for a 49% share of the new JV; Fosun is contributing its distribution network and expertise. Over time, the two companies envision bringing additional Atrium products to China. More details.... Stock Symbols: (SHA: 600196; HK: 2196) (TSX: ATB) Share this with colleagues: // //